14 sept. 2026•3 min de lecture
White House Releases Second MFN Drug Pricing Negotiation Results for Mid‑Size Pharma
The White House disclosed the second round of MFN drug‑price negotiations, now focusing on mid‑size pharmaceutical and biotech firms such as Alcon, Astellas and Teva.